Cargando…

A001 MRNA COVID-19 VACCINE ADVERSE EVENTS FOLLOWING IMMUNIZATION: SHOULD YOU RECOMMEND THE SECOND DOSE?

Detalles Bibliográficos
Autores principales: St. Clair, B., Hoffman, D., Lee, R., Montgomery, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566862/
http://dx.doi.org/10.1016/j.anai.2021.08.018
_version_ 1784594108269985792
author St. Clair, B.
Hoffman, D.
Lee, R.
Montgomery, J.
author_facet St. Clair, B.
Hoffman, D.
Lee, R.
Montgomery, J.
author_sort St. Clair, B.
collection PubMed
description
format Online
Article
Text
id pubmed-8566862
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85668622021-11-04 A001 MRNA COVID-19 VACCINE ADVERSE EVENTS FOLLOWING IMMUNIZATION: SHOULD YOU RECOMMEND THE SECOND DOSE? St. Clair, B. Hoffman, D. Lee, R. Montgomery, J. Ann Allergy Asthma Immunol Adverse Drug Reactions, Insect Reactions, Anaphylaxis Published by Elsevier Inc. 2021-11 2021-11-04 /pmc/articles/PMC8566862/ http://dx.doi.org/10.1016/j.anai.2021.08.018 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Adverse Drug Reactions, Insect Reactions, Anaphylaxis
St. Clair, B.
Hoffman, D.
Lee, R.
Montgomery, J.
A001 MRNA COVID-19 VACCINE ADVERSE EVENTS FOLLOWING IMMUNIZATION: SHOULD YOU RECOMMEND THE SECOND DOSE?
title A001 MRNA COVID-19 VACCINE ADVERSE EVENTS FOLLOWING IMMUNIZATION: SHOULD YOU RECOMMEND THE SECOND DOSE?
title_full A001 MRNA COVID-19 VACCINE ADVERSE EVENTS FOLLOWING IMMUNIZATION: SHOULD YOU RECOMMEND THE SECOND DOSE?
title_fullStr A001 MRNA COVID-19 VACCINE ADVERSE EVENTS FOLLOWING IMMUNIZATION: SHOULD YOU RECOMMEND THE SECOND DOSE?
title_full_unstemmed A001 MRNA COVID-19 VACCINE ADVERSE EVENTS FOLLOWING IMMUNIZATION: SHOULD YOU RECOMMEND THE SECOND DOSE?
title_short A001 MRNA COVID-19 VACCINE ADVERSE EVENTS FOLLOWING IMMUNIZATION: SHOULD YOU RECOMMEND THE SECOND DOSE?
title_sort a001 mrna covid-19 vaccine adverse events following immunization: should you recommend the second dose?
topic Adverse Drug Reactions, Insect Reactions, Anaphylaxis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566862/
http://dx.doi.org/10.1016/j.anai.2021.08.018
work_keys_str_mv AT stclairb a001mrnacovid19vaccineadverseeventsfollowingimmunizationshouldyourecommendtheseconddose
AT hoffmand a001mrnacovid19vaccineadverseeventsfollowingimmunizationshouldyourecommendtheseconddose
AT leer a001mrnacovid19vaccineadverseeventsfollowingimmunizationshouldyourecommendtheseconddose
AT montgomeryj a001mrnacovid19vaccineadverseeventsfollowingimmunizationshouldyourecommendtheseconddose